Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization ...

InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...

InflaRx's Gohibic received Emergency Use Authorization (EUA) from the US FDA for treating severe COVID-19 cases. Gohibic, an anti-C5a monoclonal antibody, may reduce mortality rates and the need for ...

Pfizer announced on Thursday that its COVID vaccine booster shot could further protect individuals from "all currently known variants" of COVID-19 — including the highly transmittable Delta variant.

Moderna announced Tuesday that it has begun the rolling submission process for full approval of its COVID-19 vaccine in adults from the U.S. Food and Drug Administration. The manufacturer will ...

Transitioning COVID-19 tests from emergency use authorization to the traditional pre-market pathway has long been a goal for the FDA. “Today’s authorization is the first at-home COVID-19 test granted ...